A Look at How Many Cancers Are Caused by Infections Worldwide

A microbiologist named Barry Marshall demonstrated that the bacterium *Helicobacter pylori* causes stomach ulcers when he ingested it, leading to his symptoms. Further research established that this bacterium can also cause stomach cancer, leading to a Nobel Prize for Marshall and Robin Warren's work. Research into cancer origins has expanded beyond infectious agents to include viruses and parasites. Data from the World Health Organization’s Global Cancer Observatory for 2024 indicates that 12 percent of worldwide cancer cases were attributed to infectious agents, including 2.3 million new cases. Among these agents, *H. pylori* caused the most new cases, followed by human papilloma virus (associated with cervical cancer), hepatitis B (linked to liver cancer), and Epstein-Barr virus (linked to certain lymphomas). Previous studies on pathogen-related cancer rates have been conducted since 1990. Mechanisms for carcinogenesis differ by agent; *H. pylori* promotes inflammation and disrupts cell adhesion in stomach lining cells, while viruses can insert into DNA to damage tumor suppressor sequences or contain oncogenes, causing uncontrolled cell division. Public health measures, such as the HPV vaccine, have demonstrated significant reductions in cervical precancer incidence and cancer deaths.

*Helicobacter pylori* infection led Barry Marshall to develop symptoms of peptic ulcer disease. The bacteria were also shown to be capable of causing stomach cancer. Marshall and Robin Warren received a Nobel Prize for their efforts. Data from the World Health Organization’s Global Cancer Observatory for 2024 showed that 12 percent of cancer cases worldwide were attributed to infectious agents, including 2.3 million new ones. *H. pylori* was responsible for the largest number of new cases. Human papilloma virus causes cervical cancer, among other cancers. Hepatitis B is linked to liver cancer. Epstein-Barr virus can cause several lymphomas. Five previous studies on worldwide rates of cancer caused by pathogens have been conducted since 1990, with the latest in 2018. The HPV vaccine reduced cervical precancer incidence by 80 percent among 20- to 24-year-olds and reduced cervical cancer deaths by 62 percent between 2008 and 2022.

The narrative moves from an anecdote about a single bacterial discovery to broad epidemiological findings regarding infectious etiology of cancer, establishing a framework that links microbial presence to pathological outcomes across various tissues. The contrast between the specific mechanism for *H. pylori* (inflammation and adhesion disruption) versus viral mechanisms (DNA damage/oncogene expression) highlights a crucial distinction: whether the driver is chronic inflammatory adaptation or direct genomic instability. The context provided by global cancer statistics places infectious agents as a significant, quantifiable factor in global pathology, yet the historical data itself is qualified by changes in data sources over time. This juxtaposition of specific biological mechanisms with massive global statistics requires examining which factors are most influential in public health strategy and risk assessment. Furthermore, the successful intervention via vaccination demonstrates that mitigation strategies for these infectious threats are achievable, suggesting that while environmental and biological risks exist, agency—through public health action—can substantially shift outcomes. The unstated implication is that focusing on prevention against pathogen transmission offers a powerful lever for cancer control, reinforcing the necessity of continued vigilance in public health administration.